489 related articles for article (PubMed ID: 25116445)
1. Targeted nanotechnology for cancer imaging.
Toy R; Bauer L; Hoimes C; Ghaghada KB; Karathanasis E
Adv Drug Deliv Rev; 2014 Sep; 76():79-97. PubMed ID: 25116445
[TBL] [Abstract][Full Text] [Related]
2. Nanotechnology in cancer diagnosis: progress, challenges and opportunities.
Zhang Y; Li M; Gao X; Chen Y; Liu T
J Hematol Oncol; 2019 Dec; 12(1):137. PubMed ID: 31847897
[TBL] [Abstract][Full Text] [Related]
3. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology.
Cheon J; Lee JH
Acc Chem Res; 2008 Dec; 41(12):1630-40. PubMed ID: 18698851
[TBL] [Abstract][Full Text] [Related]
4. Detecting and destroying cancer cells in more than one way with noble metals and different confinement properties on the nanoscale.
Dreaden EC; El-Sayed MA
Acc Chem Res; 2012 Nov; 45(11):1854-65. PubMed ID: 22546051
[TBL] [Abstract][Full Text] [Related]
5. Quantum dots and multifunctional nanoparticles: new contrast agents for tumor imaging.
Rhyner MN; Smith AM; Gao X; Mao H; Yang L; Nie S
Nanomedicine (Lond); 2006 Aug; 1(2):209-17. PubMed ID: 17716110
[TBL] [Abstract][Full Text] [Related]
6. In vivo assembly of nanoparticle components to improve targeted cancer imaging.
Perrault SD; Chan WC
Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11194-9. PubMed ID: 20534561
[TBL] [Abstract][Full Text] [Related]
7. Modified natural nanoparticles as contrast agents for medical imaging.
Cormode DP; Jarzyna PA; Mulder WJ; Fayad ZA
Adv Drug Deliv Rev; 2010 Mar; 62(3):329-38. PubMed ID: 19900496
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectives.
Hahn MA; Singh AK; Sharma P; Brown SC; Moudgil BM
Anal Bioanal Chem; 2011 Jan; 399(1):3-27. PubMed ID: 20924568
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of Bombesin-superparamagnetic iron oxide nanoparticles as a targeted contrast agent for imaging of breast cancer using MRI.
Jafari A; Salouti M; Shayesteh SF; Heidari Z; Rajabi AB; Boustani K; Nahardani A
Nanotechnology; 2015 Feb; 26(7):075101. PubMed ID: 25642737
[TBL] [Abstract][Full Text] [Related]
10. What is cancer nanotechnology?
Grobmyer SR; Iwakuma N; Sharma P; Moudgil BM
Methods Mol Biol; 2010; 624():1-9. PubMed ID: 20217585
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle contrast agents for X-ray imaging applications.
Hsu JC; Nieves LM; Betzer O; Sadan T; Noël PB; Popovtzer R; Cormode DP
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Nov; 12(6):e1642. PubMed ID: 32441050
[TBL] [Abstract][Full Text] [Related]
12. Facile Synthesis of Biocompatible Fluorescent Nanoparticles for Cellular Imaging and Targeted Detection of Cancer Cells.
Tang F; Wang C; Wang X; Li L
ACS Appl Mater Interfaces; 2015 Nov; 7(45):25077-83. PubMed ID: 26544019
[TBL] [Abstract][Full Text] [Related]
13. Current status of nanoparticle-based imaging agents for early diagnosis of cancer and atherosclerosis.
Saravanakumar G; Kim K; Park JH; Rhee K; Kwon IC
J Biomed Nanotechnol; 2009 Feb; 5(1):20-35. PubMed ID: 20055103
[TBL] [Abstract][Full Text] [Related]
14. Nanotechnology for cancer diagnostics: promises and challenges.
Grodzinski P; Silver M; Molnar LK
Expert Rev Mol Diagn; 2006 May; 6(3):307-18. PubMed ID: 16706735
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
[TBL] [Abstract][Full Text] [Related]
16. Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.
Babu A; Templeton AK; Munshi A; Ramesh R
AAPS PharmSciTech; 2014 Jun; 15(3):709-21. PubMed ID: 24550101
[TBL] [Abstract][Full Text] [Related]
17. Nanotechnology for early cancer detection.
Choi YE; Kwak JW; Park JW
Sensors (Basel); 2010; 10(1):428-55. PubMed ID: 22315549
[TBL] [Abstract][Full Text] [Related]
18. Towards multimodal nanoparticle labels for molecular imaging of biological processes.
Babinec P; Babincová M
Med Hypotheses; 2007; 69(3):703-4. PubMed ID: 17329036
[No Abstract] [Full Text] [Related]
19. Nanoparticles for concurrent multimodality imaging and therapy: the dawn of new theragnostic synergies.
Lucignani G
Eur J Nucl Med Mol Imaging; 2009 May; 36(5):869-74. PubMed ID: 19288097
[No Abstract] [Full Text] [Related]
20. Nanotechnology and atherosclerosis imaging: emerging diagnostic and therapeutic applications.
Schoenhagen P; Conyers JL
Recent Pat Cardiovasc Drug Discov; 2008 Jun; 3(2):98-104. PubMed ID: 18537760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
